Myriam Chalabi

16PUBLICATIONS
133CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oncology and carcinogenesis not elsewhere classifiedInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Feb 05, 2026
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group.

Ylva A Weeda, Roberto Salgado, Filip van Herpe

|Oct 20, 2025
Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers.

Pedro B Tan, Yara L Verschoor, José G van den Berg

|Jun 24, 2025
The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types.

Gil Awada, Tina Cascone, Michiel S van der Heijden

|Nov 27, 2024
Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer.

Thierry Andre, Elena Elez, Eric Van Cutsem

|Sep 15, 2024
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial.

Peter G M de Gooyer, Yara L Verschoor, Lauren D W van den Dungen

|Aug 08, 2024
Management of Locally Advanced Rectal Cancer: ASCO Guideline.

Aaron J Scott, Erin B Kennedy, Jordan Berlin

Pageof 3

Frequent Collaborators

7 joint publications

Emile E Voest

6 joint publications

Ton N Schumacher

6 joint publications

John B Haanen

5 joint publications

Yara L Verschoor